These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia. Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822 [TBL] [Abstract][Full Text] [Related]
23. Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study. Ogura M; Harada-Shiba M; Masuda D; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S; Yamashita S J Atheroscler Thromb; 2022 Jun; 29(6):906-922. PubMed ID: 34108342 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733 [TBL] [Abstract][Full Text] [Related]
25. Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. Hausmann D; Johnson JA; Sudhir K; Mullen WL; Friedrich G; Fitzgerald PJ; Chou TM; Ports TA; Kane JP; Malloy MJ; Yock PG J Am Coll Cardiol; 1996 Jun; 27(7):1562-70. PubMed ID: 8636537 [TBL] [Abstract][Full Text] [Related]
26. Extracorporeal LDL cholesterol elimination (25 years of experience in CZ). Blaha M; Zadak Z; Blaha V; Andrys C; Havel E; Vyroubal P; Blazek M; Filip S; Lanska M; Maly J Atheroscler Suppl; 2009 Dec; 10(5):17-20. PubMed ID: 20129368 [TBL] [Abstract][Full Text] [Related]
27. Positive family history for coronary heart disease and 'midband lipoproteins' are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia. Taira K; Bujo H; Kobayashi J; Takahashi K; Miyazaki A; Saito Y Atherosclerosis; 2002 Feb; 160(2):391-7. PubMed ID: 11849663 [TBL] [Abstract][Full Text] [Related]
28. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Kroon AA; van Asten WN; Stalenhoef AF Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704 [TBL] [Abstract][Full Text] [Related]
29. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study. Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444 [TBL] [Abstract][Full Text] [Related]
30. [A case of heterozygous familial hypercholesterolemia showing the regression of coronary atherosclerosis by LDL-apheresis]. Nomura S; Kouzuma R; Komura T; Sadayasu T; Segawa J; Nakashima Y; Kuroiwa A Kokyu To Junkan; 1992 Mar; 40(3):299-302. PubMed ID: 1579754 [TBL] [Abstract][Full Text] [Related]
31. Apheresis technology for prevention and regression of atherosclerosis. Yamamoto A; Harada-Shiba M; Kawaguchi A; Tsushima M Ther Apher; 2001 Aug; 5(4):221-5. PubMed ID: 11724504 [TBL] [Abstract][Full Text] [Related]
33. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia. Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234 [TBL] [Abstract][Full Text] [Related]
34. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Koga N Ther Apher; 2001 Aug; 5(4):244-51. PubMed ID: 11724508 [TBL] [Abstract][Full Text] [Related]
37. Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country. Khoo KL; Page MM; Liew YM; Defesche JC; Watts GF J Clin Lipidol; 2016; 10(5):1188-94. PubMed ID: 27678436 [TBL] [Abstract][Full Text] [Related]
38. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures. van Buuren F; Kreickmann S; Horstkotte D; Kottmann T; Mellwig KP Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):24-30. PubMed ID: 22528135 [TBL] [Abstract][Full Text] [Related]